Key result
Long-term anabolic steroid use is linked to lower LVEF, with partial recovery after discontinuation.
Why the study?
Does discontinuation of anabolic-androgenic steroids improve myocardial structure and function in long-term users compared to continued use?
Population
45 males, comprising 32 anabolic-androgenic steroid users and 13 strength-trained non-users.
Comparison
Anabolic-androgenic steroid use. vs Strength-trained male non-users (controls).
Design
Cohort
Follow-up
median 16 years for AAS users, 13 years for controls
Authors
Loading...
Discontinuation of long-term anabolic-androgenic steroid use is associated with partial recovery of left ventricular systolic dysfunction over a decade.
Cohort (n=45)
Does discontinuation of anabolic-androgenic steroids improve myocardial structure and function in long-term users compared to continued use?
Absolute Event Rate: 50% vs 54%
p-value: p=<0.01
Discontinuation of long-term anabolic-androgenic steroid use is associated with partial recovery of left ventricular systolic dysfunction over a decade.
Fyksen et al. (2025) conducted a cohort in Anabolic-androgenic steroid use (n=45). Anabolic-androgenic steroids (AAS) vs. Strength-trained non-using athletes was evaluated on Left ventricular ejection fraction (LVEF) at follow-up (p=<0.01). Long-term anabolic-androgenic steroid use was associated with impaired left ventricular ejection fraction compared to controls (50% vs 54%, p<0.01), with partial recovery upon discontinuation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: